These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18600101)

  • 1. Evaluation of urokinase plasminogen activator in urine from individuals with Quebec platelet disorder.
    Diamandis M; Veljkovic DK; Derome F; Rivard GE; Hayward CP
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):463-4. PubMed ID: 18600101
    [No Abstract]   [Full Text] [Related]  

  • 2. Quebec platelet disorder: features, pathogenesis and treatment.
    Diamandis M; Veljkovic DK; Maurer-Spurej E; Rivard GE; Hayward CP
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):109-19. PubMed ID: 18277131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene.
    Paterson AD; Rommens JM; Bharaj B; Blavignac J; Wong I; Diamandis M; Waye JS; Rivard GE; Hayward CP
    Blood; 2010 Feb; 115(6):1264-6. PubMed ID: 20007542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of proteomics for the diagnosis of a platelet-related bleeding disorder.
    Maurer-Spurej E; Kahr WH; Carter CJ; Pittendreigh C; Cameron M; Cyr TD
    Platelets; 2008 Aug; 19(5):342-51. PubMed ID: 18791940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes.
    Diamandis M; Paterson AD; Rommens JM; Veljkovic DK; Blavignac J; Bulman DE; Waye JS; Derome F; Rivard GE; Hayward CP
    Blood; 2009 Feb; 113(7):1543-6. PubMed ID: 18988861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of urokinase in the urine using thrombelastography and the fibrin-plate test].
    Stein G; Lindner M; Schultz C; Neumann W
    Z Gesamte Inn Med; 1974 Dec; 29(24):1027-30. PubMed ID: 4458319
    [No Abstract]   [Full Text] [Related]  

  • 7. [Product E, urokinase and uropepsinogen in the urine of diabetic children].
    Symonides-Lawecka A; Galczak W; Olech K; Wysocki M
    Pediatr Pol; 1978 May; 53(5):593-8. PubMed ID: 683753
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
    Zhou H; Wu X; Lu X; Chen G; Ye X; Huang J
    Thromb Res; 2009; 123(3):537-42. PubMed ID: 18691743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line.
    Gach K; Szemraj J; Fichna J; Piestrzeniewicz M; Delbro DS; Janecka A
    Chem Biol Drug Des; 2009 Oct; 74(4):390-6. PubMed ID: 19691469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on quantitative determination of urokinase by radioimmunoassay and its clinical application. Part I. A new radioimmunoassay method for the quantitative determination of urokinase in urine (author's transl)].
    Wakayama Y
    Nihon Ketsueki Gakkai Zasshi; 1975 Oct; 38(5):582-8. PubMed ID: 1243728
    [No Abstract]   [Full Text] [Related]  

  • 11. The urokinase system in patients with intermittent and persistent allergic rhinitis.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):685-8. PubMed ID: 18832910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of kallikrein excretion in the urine].
    Klauser RJ; Blümel G
    Med Welt; 1980 Apr; 31(14):521-2. PubMed ID: 6154862
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleeding risks associated with inheritance of the Quebec platelet disorder.
    McKay H; Derome F; Haq MA; Whittaker S; Arnold E; Adam F; Heddle NM; Rivard GE; Hayward CP
    Blood; 2004 Jul; 104(1):159-65. PubMed ID: 15026313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer.
    Milanese G; Dellabella M; Fazioli F; Pierpaoli E; Polito M; Siednius N; Montironi R; Blasi F; Muzzonigro G
    J Urol; 2009 Mar; 181(3):1393-400. PubMed ID: 19157433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of urokinase-type plasminogen activator genotypes in gastric cancer.
    Wu CY; Wu MS; Chen YJ; Chen HP; Chen CJ; Chang CS; Lin JT
    Hepatogastroenterology; 2008; 55(86-87):1890-4. PubMed ID: 19102416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients.
    De Cremoux P; Grandin L; Diéras V; Savignoni A; Degeorges A; Salmon R; Bollet MA; Reyal F; Sigal-Zafrani B; Vincent-Salomon A; Sastre-Garau X; Magdelénat H; Mignot L; Fourquet A;
    Anticancer Res; 2009 May; 29(5):1475-82. PubMed ID: 19443353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aetiology and outcomes of secondary myelofibrosis occurring in the context of inherited platelet disorders: A single institutional study of four patients.
    Saliba AN; Ferrer A; Gangat N; Pruthi RK; Tefferi A; Higgins A; Bezerra ED; Buglioni A; Salama ME; Klee EW; Pinto E Vairo F; Mangaonkar A; Majerus J; Chen D; Patnaik MM
    Br J Haematol; 2020 Sep; 190(5):e316-e320. PubMed ID: 32567678
    [No Abstract]   [Full Text] [Related]  

  • 18. Activated platelets increase fibrinolysis of mesenchymal progenitor cells.
    Agis H; Kandler B; Fischer MB; Watzek G; Gruber R
    J Orthop Res; 2009 Jul; 27(7):972-80. PubMed ID: 19030175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ovine urokinase plasminogen activator and its receptor cDNAs: molecular cloning, characterization and expression in various tissues.
    Theodorou G; Bizelis I; Rogdakis E; Politis I
    Gene; 2009 Aug; 443(1-2):158-69. PubMed ID: 19389465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy.
    Naruse K; Lash GE; Bulmer JN; Innes BA; Otun HA; Searle RF; Robson SC
    Placenta; 2009 May; 30(5):398-404. PubMed ID: 19272641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.